Reliv’s licensing agreement wasn’t the only big lunasin news to come out of conference. During a special science presentation, research scientist Dr. Alfredo Galvez shared the results of a University of Missouri study using a combination of Reliv Now® and LunaRich X with overweight pigs, animals whose physiology is very similar to humans.
How were those results? “Remarkable,” Dr. Galvez said. “We went into the experiment looking for improved cholesterol, but we found so much more. The improvement in several key biomarkers suggests that a supplementation program with these two products may significantly lower certain health risks.”
“The study also confirmed that the combination of Reliv Now and LunaRich X produced markedly better results than LunaRich X alone,” Dr. Carl Hastings added. “This confirms lunasin’s ability to work synergistically with other bioactive nutrients in Reliv products to boost benefits.”
Read more about this study and plans for further research on the health benefits of lunasin!